GENDATA RESEARCH CORPORATION ANNOUNCES COLLABORATION WITH AMGEN

GenData has announced a collaborative sponsored research and exclusive license agreement with Amgen for the discovery, development and commercialization of therapeutics and diagnostics aimed at an undisclosed disorder. Under the collaboration, Amgen will select genetic targets identified by GenData's powerful population genetics discovery platform. The terms of the collaboration include sponsored research activities, product development milestones, and financial consideration associated with therapeutic and diagnostic products that result from the collaboration.

Pharmaceutical Business Review Online (http://www.pharmaceutical-business-review.com/article_news.asp?guid=1356D6E7-8F43-4378-ABB3-107C62743213)